ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+44.08%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$128M
AUM Growth
+$128M
(-24%)
Cap. Flow
-$42.9M
Cap. Flow
% of AUM
-33.52%
Top 10 Holdings %
Top 10 Hldgs %
60.63%
Holding
108
New
16
Increased
5
Reduced
5
Closed
41
Top Buys
| 1 |
IMGN
Immunogen Inc
IMGN
|
$9.15M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$8.78M |
| 3 |
GRI Bio
GRI
|
$5.01M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$4.49M |
| 5 |
Harmony Biosciences
HRMY
|
$4.22M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$8.15M |
| 2 |
Arcellx
ACLX
|
$4.62M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$4.58M |
| 4 |
Glaukos
GKOS
|
$4.56M |
| 5 |
Penumbra
PEN
|
$4.46M |
Sector Composition
| 1 | Healthcare | 95.31% |
| 2 | Financials | 1.22% |
| 3 | Technology | 1.22% |
| 4 | Communication Services | 0.46% |
| 5 | Materials | 0.21% |
